FRA40 index rose 1.0% during today's session, outperforming its regional peers and approaching all-time high established in January of 2022, boosted by slew of upbeat corporate earnings. Orange (ORA.FR) stock surged 5.7% after the company presented its new “ Lead the future ” strategic plan, which aims "to promote recognized excellence in its core business and to grow sustainably in Europe, Africa and the Middle East ”. Pernod Ricard (RI.FR) stock trades nearly 4.0% higher, after the spirits company posted better than expected revenue figures in the first half mainly thanks to price increases. Meanwhile, Airbus (AIR.FR) shares advanced more than 3%, after the company announced plans to deliver 720 aircraft this year compared to 611 in 2022.
From a technical point of view, the French index rose over 30.0% from September lows and is currently testing record high at 7400 pts, however hidden bearish divergence appeared on the Momentum indicator, which indicates that the recent upward rally may be losing steam. If sellers manage to regain control, downward impulse may be launched towards support at 6515 pts which coincides with 23.6% Fibonacci retracement of the upward wave launched in March 2020.
FRA40, W1 interval. Source: xStation5
Daily Summary - Powerful NFP report could delay Fed rate cuts
Palo Alto acquires CyberArk. A new leader in cybersecurity!
US OPEN: Blowout Payrolls Signal Slower Path for Rate Cuts?
BREAKING: US100 jumps amid stronger than expected US NFP report
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
